Select country change
Shopping cart (0 , 0,00 ) Menu Search
13 \ 07 \ 2020

BioVendor R&D new products July 2020

13683

Dear customer, we would like to introduce our new products from July 2020 and hope you will find them interesting.

12176

NEW PROTEINS


CAT. NO. SPECIES NAME SIZE SOURCE
RN0001100 Human ACE2 (18-615) 100 µg CHO cells
RN0001020 Human ACE2 (18-615) 20 µg CHO cells
RP1791127005 Human ACE2 (18-740), Biotinylated 5 µg HEK293
RP1791127050 Human ACE2 (18-740), Biotinylated 50 µg HEK293
RN0002100 Human ACE2 (19-740) 100 µg CHO cells
RN0002020 Human ACE2 (19-740) 20 µg CHO cells
RD172592100 Human CTGF N-terminus 0.1 mg E. coli
RD172124025 Human ENPP1 Protein 0.025 mg HEK293
RD275597100 Mouse ENPP1 Protein 0.1 mg HEK293
RD172575100 Human Fibroblast growth factor 7 0.1 mg E. coli
RD172604100 Human IGF-1 E3R 0.1 mg E. coli
RD175006100 Human Procalcitonin 0.1 mg HEK293
RP17910150100 Tritirachium
album
Proteinase-K 100 mg Yeast
RP1791015100 Tritirachium
album
Proteinase-K 1 g Yeast
RD975598100 SARS SARS-CoV-2 Nucleocapsid Protein (NP) 0.1 mg HEK293
RN0005100 SARS SARS-CoV-2 Spike Glycoprotein S1 100 µg HEK293
RN0005500 SARS SARS-CoV-2 Spike Glycoprotein S1 500 µg HEK293
RN0012100 SARS SARS-CoV-2 Spike Glycoprotein S1 100 µg Insect Cells
RN0012500 SARS SARS-CoV-2 Spike Glycoprotein S1 500 µg Insect Cells
RN0006100 SARS SARS-CoV-2 Spike Glycoprotein S1 RBD 100 µg HEK293
RN0006500 SARS SARS-CoV-2 Spike Glycoprotein S1 RBD 500 µg HEK293
RN0007020 SARS SARS-CoV-2 Spike Glycoprotein S1 RBD 20 µg CHO cells
RN0007100 SARS SARS-CoV-2 Spike Glycoprotein S1 RBD 100 µg CHO cells
RN0008020 SARS SARS-CoV-2 Spike Glycoprotein S1 RBD, Fc 20 µg CHO cells
RN0008100 SARS SARS-CoV-2 Spike Glycoprotein S1 RBD, Fc 100 µg CHO cells
RN0005100H SARS SARS-CoV-2 Spike Glycoprotein S1, HRP labelled 100 µg HEK293
RN0004100 SARS SARS-CoV-2 Spike Glycoprotein S2 100 µg HEK293
RN0004500 SARS SARS-CoV-2 Spike Glycoprotein S2 500 µg HEK293
RN0009100 SARS SARS-CoV-2 Spike Glycoprotein S2 100 µg Insect Cells
RN0009500 SARS SARS-CoV-2 Spike Glycoprotein S2 500 µg Insect Cells
RN0011100 SARS SARS-CoV-2 Spike Glycoprotein S2 (1000-1200) 100 µg E. coli
RN0011500 SARS SARS-CoV-2 Spike Glycoprotein S2 (1000-1200) 500 µg E. coli
RN0010100 SARS SARS-CoV-2 Spike Glycoprotein S2 (800-1000) 100 µg E. coli
RN0010500 SARS SARS-CoV-2 Spike Glycoprotein S2 (800-1000) 500 µg E. coli
RN0004100H SARS SARS-CoV-2 Spike Glycoprotein S2, HRP labelled 100 µg HEK293
RN0003100 SARS SARS-CoV-2 Spike N-Terminal Domain NTD 100 µg HEK293
RN0003500 SARS SARS-CoV-2 Spike N-Terminal Domain NTD 500 µg HEK293
RI975603100 SARS SARS-CoV-2 Spike S1 protein 100 µg HEK293

Featured product: 

HEK293-expressed SARS-CoV-2 Nucleocapsid Protein (NP) (RD975598100) 

and 

SARS-CoV-2 Spike Glycoprotein S1 RBD (RN0006100)

Nucleocapsid protein (NP) is the most abundant protein on the helical nucleocapsid of coronavirus, which envelopes the entire genomic RNA. The S1 subunit binds the cellular receptor through its receptor-binding domain (RBD), followed by conformational changes in the S2 subunit, which allows the fusion peptide to insert into the host target cell membrane.

The two proteins are frequently used as immobilized antigens in anti-COVID-19 antibody detection tests (ELISA, Immunochromatography rapid tests, etc).

Commonly used E.coli-produced antigens may contain traces of host (E.coli) proteins and interfere with anti-E.coli antibodies circulating in human sera. This represents an increased risk of obtaining non-specific results.

The HEK293-expressed proteins are free of host bacteria protein contamination and the risk of non-specific results is minimized.

See more about HEK293-expressed SARS-CoV-2 Nucleocapsid Protein (NP) (RD975598100) and SARS-CoV-2 Spike Glycoprotein S1 RBD (RN0006100)


12174

NEW miREIA KITS

CAT. NO. NAME ASSAY FORMAT
RDM0043B blv-miR-B1-3p miREIA – miRNA enzyme immunoassay

Featured product: blv-miR-B1-3p miREIA

blv-miR-B1-3p is one of the miRNAs encoded by Bovine Leukemia Virus (BLV).

BLV is a deltaretrovirus closely related to the Human T cell leukemia virus-1 (HTLV-1) and is estimated to infect over 83% of dairy herds and over 40% of all dairy cows in the United States. 

Retroviruses were not expected to encode miRNAs because of the potential problem of self-cleavage of their genomic RNAs. This assumption has recently been challenged by experiments showing that BLV encodes miRNAs from intragenomic Pol III promoters. 

BLV miRNAs mediate the expression of genes involved in cell signaling, cancer, and immunity. BLV miRNAs are essential to induce B-cell tumors in an experimental model and to promote efficient viral replication in the natural host.

BLV only causes leukemia in a small proportion of animals, but BLV+ cattle exhibit reduced milk production and longevity that is distinct from lymphoma development. BLV negatively affects production by interfering with cattle immunity and increasing the risk of secondary infections.

See more about blv-miR-B1-3p miREIA

For this and more BioVendor miREIA kits, please visit www.biovendor.com/mirna.

ON-REQUEST miREIA Production

Can't find what you are looking for? Do you need a miREIA kit that is not in our portfolio yet? Or perhaps a customized assay?

Contact us at microRNA@biovendor.com

Scheduling of custom miREIA production is described here: ON-REQUEST miREIA Production


13686

BioVendor Analytical Testing Service

YOU KNOW WHAT – WE KNOW HOW

Get certified sample analysis directly from the source with our BATS.

Combining the expertise and experience of 25 years in research, development and manufacturing of immunoassays, BioVendor provides analytical services for universities, clinical centres, pharmaceutical and biotechnological industries. An extensive range of analytical solutions enable us to provide you with a perfect service for your research or product development.

What we measure 

 

  • Small non-coding RNA (miRNA, piRNA)
  • Diagnostic biomarkers (hormones, cytokines)

 

Our methods 

 

  • Quantitative analysis of small non-coding RNA (miRNA, piRNA) by RT-qPCR or miRNA immunoassys
  • Hormones and cytokines (ELISA)
  • High-throughput multiplex analysis (Luminex)

 

 

GET IN TOUCH

Website: www.biovendor.com/biovendor-analytical-testing-service
E-mail: bats@biovendor.com
Phone: +420 549 124 185

 


Protein and miRNA Markers in Pulmonary Diseases | BioVendor Webinar #3

The COVID-19 pandemic brought attention to pulmonary diseases and associated laboratory diagnosis markers. Pneumonia and acute respiratory distress syndrome (ARDS) represented the most deadly conditions in COVID-19 patients leaving behind survivors suffering from lung fibrosis scares or other critical pulmonary complications. We are going to exploit a long history of pulmonary disease biomarkers development in BioVendor and share our knowledge with you.

Key points covered in this webinar:

 

  • Protein markers in Pulmonary disease 
  • miRNA biomarkers in Pulmonary diseases 
  • The role of miRNAs in COVID-19 development and protection 
  • Please see the webinar here.


Protein and miRNA Markers in Pulmonary Diseases

 

BioVendor News Let's keep in touch!

Click to sign up for our newsletter to receive regular updates: NEWLETTER

More information about your data protection rights can be found at Privacy Policy

Blog Categories:


Tags:

Share:

Blog Categories

Archives